Literature DB >> 14762832

Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience.

Massimo Roncalli1.   

Abstract

The spectrum of so-called space-occupying small (0.5-2.5 cm) sizable nodules arising in the cirrhotic liver includes a series of hyperplastic (large regenerative), dysplastic (low- and high-grade dysplastic), and malignant hepatocellular (well-differentiated hepatocellular carcinoma, HCC) nodules. Major progress in their classification and understanding was achieved through image analysis techniques and careful histological dissection of explanted native livers. Needless to say, the actual understanding of their natural history is crucial to a proper histological classification. The differential diagnosis of these hepatocellular nodules is difficult, particularly on biopsy specimens of focal liver lesions revealed by ultrasound (US), taken during the follow-up of cirrhotic patients. In this study we attempted to summarize, on the basis of our experience, essential clinicopathological features useful to distinguish the different nodules on needle biopsy. Synoptic tables of differential diagnosis and figures of elementar lesions, which have to be looked for, are provided. Only the continuous integration of clinical features, image analysis information of pathological findings, and follow-up data allows establishing the autonomy of these polymorphic and controversial entities and the boundaries between them.

Entities:  

Mesh:

Year:  2004        PMID: 14762832     DOI: 10.1002/lt.20047

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  9 in total

Review 1.  Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?

Authors:  J Schölmerich; D Schacherer
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.

Authors:  Enzo Ierardi; Rosa Rosania; Mariangela Zotti; Floriana Giorgio; Simonetta Prencipe; Nicola Della Valle; Vincenzo De Francesco; Carmine Panella
Journal:  World J Gastrointest Oncol       Date:  2010-06-15

3.  Keratin 19 epithelial patterns in cirrhotic stroma parallel hepatocarcinogenesis.

Authors:  Jochen K M Lennerz; William C Chapman; Elizabeth M Brunt
Journal:  Am J Pathol       Date:  2011-06-23       Impact factor: 4.307

4.  Histological features of early hepatocellular carcinomas and their developmental process: for daily practical clinical application : Hepatocellular carcinoma.

Authors:  Fukuo Kondo
Journal:  Hepatol Int       Date:  2008-11-14       Impact factor: 6.047

Review 5.  Histopathology of hepatocellular carcinoma.

Authors:  Manuel Schlageter; Luigi Maria Terracciano; Salvatore D'Angelo; Paolo Sorrentino
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 6.  Current role of ultrasound for the management of hepatocellular carcinoma.

Authors:  Hitoshi Maruyama; Masaharu Yoshikawa; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 7.  Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.

Authors:  Carlo Bartolozzi; Laura Crocetti; Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Daniela Campani
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 7.034

8.  Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma.

Authors:  Aileen Wee
Journal:  Cytojournal       Date:  2005-06-08       Impact factor: 2.091

9.  Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.

Authors:  Chung Seop Lee; Yong Jin Jung; Soon Sun Kim; Jae Youn Cheong; Ga Ram Lee; Han Gyeol Kim; Beom Hee Kim; Jung Wha Chung; Eun Sun Jang; Sook-Hyang Jeong; Kyung Ho Lee; Jin-Wook Kim
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.